Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany

Abstract

Aim Thyroid scintigraphy enables the depiction of the functional status of thyroid nodules (TNs) with both, ^99mTc-pertechnetate and ¹²³Iodine. The functional status is relevant for diagnostic procedures for the differentiation of benign and malignant TNs. The aim of this study was to examine the current frequencies of hyper-, hypo- and isofunctioning TNs in Germany and to estimate the risk of malignancy with regard to functional status.

Methods In 11 study centers, a minimum of 100 nodules per center were consecutively enrolled between July 2019 and April 2020. Inclusion criteria were: newly diagnosed nodule, nodule’ size of 10 mm or more, thyroid scintigraphy. Exclusion criteria were: completely cystic TNs, patients with prior radioiodine therapy or thyroid surgery. The risk of malignancy was estimated for hyper- and hypofunctioning TNs.

Results Overall, 849 patients (72 % women) with 1262 TNs were included. Patients’ age ranged from 18 to 90 years. Most TNs were hypofunctioning (n=535, 42%) followed by isofunctioning TNs (n=488, 39%) and hyperfunctioning TNs (n=239, 19%). When only TNs with a maximum size of 2 cm or more were considered the rate of hyperfunctioning and hypofunctioning TNs increased (to 27% and 49%) while isofunctioning TNs decreased. Only one of all hyperfunctioning TNs was malignant. In hypofunctioning nodules, the malignancy rate was estimated at 10%.

Conclusion In Germany, the proportion of hyperfunctioning TNs is approximately 20% and increases in larger TNs to up to 27%. Due to the low risk of malignancy in hyperfunctioning TNs, no further procedures to rule out malignancy are necessary. The risk of malignancy of hypofunctioning TNs is significantly higher. Thus, a thyroid scintigraphy is a useful diagnostic tool in Germany.

Keywords

Hyperfunctioning thyroid nodules - Hypofunctioning thyroid nodules - Thyroid scintigraphy - Risk of malignancy

Publikationsverlauf

Eingereicht: 07. Dezember 2021

Angenommen nach Revision: 12. Mai 2022

Artikel online veröffentlicht:
02. August 2022

• References

• 1 Giovanella L, Avram AM, Iakovou I. et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging 2019; 46: 2514-2525 DOI: 10.1007/s00259-019-04472-8. (PMID: 31392371)
• 2 Dietlein M, Wegscheider K, Vaupel R. et al. Survey of management of solitary thyroid nodules in Germany. Nuklearmedizin 2008; 47: 87-96 (PMID: 18493687)
• 3 Seifert P, Freesmeyer M. Preoperative diagnostics in differentiated thyroid carcinoma. Nuklearmedizin 2017; 56: 201-210 DOI: 10.3413/Nukmed-0924-17-08. (PMID: 29044289)
• 4 Perros P, Boelaert K, Colley S. et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 2014; 81: 1-122 DOI: 10.1111/cen.12515. (PMID: 24989897)
• 5 Haugen BR, Alexander EK, Bible KC. et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26: 1-133 DOI: 10.1089/thy.2015.0020. (PMID: 26462967)
• 6 Dietlein M, Eschner W, Lassmann M. et al. Procedure Guideline for Thyroid Scintigraphy (Version 4) 2014. Im Internet: www.nuklearmedizin.de/leistungen/leitlinien/docs/031–011I_S1_Schiilddrüsenszintigraphie_2014–10.pdf; Stand: 25.03.2021.
• 7 Görges R, Kandror T, Kuschnerus S. et al. Scintigraphically “hot” thyroid nodules mainly go hand in hand with a normal TSH. Nuklearmedizin 2011; 50: 179-188 DOI: 10.3413/nukmed-0386-11-02. (PMID: 21789340)
• 8 Schenke S, Seifert P, Zimny M. et al. Risk stratification of thyroid nodules using Thyroid Imaging Reporting And Data System (TIRADS): The omission of thyroid scintigraphy increases the rate of falsely suspected lesions. J Nucl Med 2018; DOI: 10.2967/jnumed.118.211912.
• 9 Seifert P, Görges R, Zimny M. et al. Interobserver agreement and efficacy of consensus reading in Kwak-, EU-, and ACR-thyroid imaging recording and data systems and ATA guidelines for the ultrasound risk stratification of thyroid nodules. Endocrine 2020; 67: 143-154 DOI: 10.1007/s12020-019-02134-1. (PMID: 31741167)
• 10 Schenke S, Klett R, Seifert P. et al. Diagnostic Performance of Different Thyroid Imaging Reporting and Data Systems (Kwak-TIRADS, EU-TIRADS and ACR TI-RADS) for Risk Stratification of Small Thyroid Nodules (≤10 mm). Journal of Clinical Medicine 2020; 9: 236 DOI: 10.3390/jcm9010236. (PMID: 31963140)
• 11 Seifert P, Schenke S, Zimny M. et al. Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter Trial. Cancers 2021; 13: 4467 DOI: 10.3390/cancers13174467. (PMID: 34503277)
• 12 Graf D, Helmich-Kapp B, Graf S. et al. Funktionelle Aktivität fokaler Schilddrüsenautonomien in Deutschland. Dtsch Med Wochenschr 2012; 137: 2089-2092 DOI: 10.1055/s-0032-1305324.
• 13 Görges R, Bockisch A, Seifert P. Die „Standard“-Schilddrüsenszintigrafie – ist sie noch zeitgemäß?. Der Nuklearmediziner 2020; 43: 201-212 DOI: 10.1055/a-1131-9692.
• 14 Kresnik E, Gallowitsch H-J, Mikosch P. et al. Scintigraphic and Ultrasonographic Appearance in Different Tumor Stages of Thyroid Carcinoma. Acta Med Austriaca 2000; 27: 32-35 DOI: 10.1046/j.1563-2571.2000.00107.x. (PMID: 10812461)
• 15 Stember JN, Sheikh A, Perez E. et al. A threshold-based method to predict thyroid nodules on scintigraphy scans. Biomed Phys Eng Express 2020; 6: 015019 DOI: 10.1088/2057-1976/ab6500. (PMID: 33438607)
• 16 Winkens T, Seifert P, Hollenbach C. et al. The FUSION iENA Study: Comparison of I-124-PET/US Fusion Imaging with Conventional Diagnostics for the Functional Assessment of Thyroid Nodules by Multiple Observers. Nuklearmedizin 2019; 58: 434-442 DOI: 10.1055/a-1031-9832. (PMID: 31711244)
• 17 Freesmeyer M, Winkens T, Kühnel C. et al. Technetium-99m SPECT/US Hybrid Imaging Compared with Conventional Diagnostic Thyroid Imaging with Scintigraphy and Ultrasound. Ultrasound in Medicine & Biology 2019; 45: 1243-1252 DOI: 10.1016/j.ultrasmedbio.2019.01.003. (PMID: 30773379)
• 18 Seifert P, Winkens T, Kühnel C. et al. I-124-PET/US Fusion Imaging in Comparison to Conventional Diagnostics and Tc-99m Pertechnetate SPECT/US Fusion Imaging for the Function Assessment of Thyroid Nodules. Ultrasound in Medicine & Biology 2019; 45: 2298-2308 DOI: 10.1016/j.ultrasmedbio.2019.05.008. (PMID: 31196748)
• 19 Freesmeyer M, Winkens T, Weissenrieder L. et al. Fusion iENA Scholar Study: Sensor-Navigated I-124-PET/US Fusion Imaging versus Conventional Diagnostics for Retrospective Functional Assessment of Thyroid Nodules by Medical Students. Sensors 2020; 20: 3409 DOI: 10.3390/s20123409. (PMID: 32560336)
• 20 Treglia G, Trimboli P, Verburg FA. et al. Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. European Journal of Clinical Investigation 2015; 45: 739-744 DOI: 10.1111/eci.12456. (PMID: 25940693)
• 21 Horst W, Rösler H, Schneider C. et al. 306 Cases of Toxic Adenoma: Clinical Aspects, Findings in Radioiodine Diagnostics, Radiochromatography and Histology; Results of 1311 and Surgical Treatment. Journal of Nuclear Medicine 1967; 8: 515-528 (PMID: 4166326)
• 22 Thermann M, Raute-Kreinsen U, Blomenkamp K. Incidence of carcinoma in follicular neoplasia of the thyroid gland. Chirurg 1992; 63: 820-821 (PMID: 1424975)
• 23 Bongiovanni M, Spitale A, Faquin WC. et al. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol 2012; 56: 333-339 DOI: 10.1159/000339959. (PMID: 22846422)
• 24 Baser H, Topaloglu O, Bilginer MC. et al. Are cytologic and histopathologic features of hot thyroid nodules different from cold thyroid nodules?. Diagn Cytopathol 2019; 47: 898-903 DOI: 10.1002/dc.24251. (PMID: 31190472)
• 25 Lau LW, Ghaznavi S, Frolkis AD. et al. Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis. Thyroid Res 2021; 14: 3 DOI: 10.1186/s13044-021-00094-1. (PMID: 33632297)
• 26 Schröder S, Marthaler B. Autonomie und Malignität bei Schilddrüsentumoren. Der Pathologe 1996; 17: 349-357 DOI: 10.1007/s002920050172.
• 27 Reschini E, Ferrari C, Castellani M. et al. The trapping-only nodules of the thyroid gland: prevalence study. Thyroid 2006; 16: 757-762 DOI: 10.1089/thy.2006.16.757. (PMID: 16910877)
• 28 Mirfakhraee S, Mathews D, Peng L. et al. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res 2013; 6: 7 DOI: 10.1186/1756-6614-6-7. (PMID: 23641736)
• 29 Liu J, Wang Y, Da D. et al. Hyperfunctioning thyroid carcinoma: A systematic review. Mol Clin Oncol 2019; 11: 535-550 DOI: 10.3892/mco.2019.1927. (PMID: 31798874)
• 30 Castellana M, Virili C, Paone G. et al. Ultrasound systems for risk stratification of thyroid nodules prompt inappropriate biopsy in autonomously functioning thyroid nodules. Clin Endocrinol (Oxf) 2020; 93: 67-75 DOI: 10.1111/cen.14204. (PMID: 32319108)
• 31 Happel C, Truong PN, Bockisch B. et al. 99mTc-Szintigraphie versus Farbduplex-Sonographie: Kann zur Diagnose der funktionellen Schilddrüsenautonomie auf die Szintigraphie verzichtet werden?. Nuklearmedizin 2013; 52: 186-191 DOI: 10.3413/Nukmed-0557-13-01.
• 32 Veer V, Puttagunta S. The role of elastography in evaluating thyroid nodules: a literature review and meta-analysis. Eur Arch Otorhinolaryngol 2015; 272: 1845-1855 DOI: 10.1007/s00405-014-3155-7. (PMID: 24997982)
• 33 Ruhlmann M, Stebner V, Görges R. et al. Diagnosis of hyperfunctional thyroid nodules: impact of US-elastography. Nuklearmedizin 2014; 53: 173-177 DOI: 10.3413/Nukmed-0660-14-04. (PMID: 24898434)
• 34 Trimboli P, Paone G, Zatelli MC. et al. Real-time elastography in autonomously functioning thyroid nodules: relationship with TSH levels, scintigraphy, and ultrasound patterns. Endocrine 2017; 58: 488-494 DOI: 10.1007/s12020-017-1277-6. (PMID: 28285385)
• 35 Berkhoff M, Ungeheuer E. Muss der kalte Knoten weiterhin als absolute Operationsindikation gelten? [Must cold nodules continue to remain absolute indications for surgery?]. Chirurg 1979; 50: 222-226
• 36 Frilling A, Autschbach R, Gomez JR. et al. 37. Kalter Strumaknoten – eine absolute Operationsindikation?. Langenbecks Arch Chiv 1986; 369: 207-208 DOI: 10.1007/BF01274354.
• 37 Scevola G, Massa G. Il nodo “freddo” della tiroide (contributo clinico-statistico) [“Cold” nodules of the thyroid gland. (Clinical statistical study)]. Minerva Chirurgica 1979; 34: 917-928
• 38 Christensen SB, Bondeson L, Ericsson UB. et al. Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin. A prospective study of 100 surgically treated patients. Acta Chir Scand 1984; 150: 433-439 (PMID: 6495973)
• 39 Oommen R, Walter NM, Tulasi NR. Scintigraphic diagnosis of thyroid cancer. Correlation of thyroid scintigraphy and histopathology. Acta Radiol 1994; 35: 222-225 (PMID: 8192956)
• 40 Lumachi F, Varotto L, Borsato S. et al. Usefulness of 99mTc-pertechnetate Scintigraphy and Fine-needle Aspiration Cytology in Patients with Solitary Thyroid Nodules and Thyroid Cancer. ANTICANCER RESEARCH 2004; 24 (04) 2531-2534 (PMID: 15330209)
• 41 Rosário PW, Salles DS, Bessa B. et al. Contribution of scintigraphy and ultrasonography to the prediction of malignancy in thyroid nodules with indeterminate cytology. Arq Bras Endocrinol Metab 2010; 54: 56-59 DOI: 10.1590/S0004-27302010000100010.
• 42 Wiyanto J, Kartamihardja AS, Nugrahadi T. Can ultrasound predict malignancy in patient with thyroid cold nodule?. World J Nucl Med 2016; 15: 179 DOI: 10.4103/1450-1147.174704. (PMID: 27651738)